Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors
Crossref DOI link: https://doi.org/10.1007/s00595-016-1310-z
Published Online: 2016-02-09
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Masui, Toshihiko
Doi, Ryuichiro
Kawaguchi, Yoshiya
Sato, Asahi
Nakano, Kenzo
Ito, Tatsuo
Anazawa, Takayuki
Takaori, Kyoichi
Uemoto, Shinji
Text and Data Mining valid from 2016-02-09